JKN2301 Dry Suspension

JKN2301 · Joincare Pharmaceutical Group Industry Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JKN2301 Dry Suspension, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza [Phase 3]

See pricing